Progressive encephalomyelitis with rigidity and myoclonus (PERM): brucellosis as a possible triggering factor and long-term follow-up therapy with rituximab

Progressive encephalomyelitis with rigidity and myoclonus (PERM): brucellosis as a possible triggering factor and long-term follow-up therapy with rituximab

Bibliographic Details
Main Authors:	Eleni E. Magira, Harry Alexopoulos, Evangelos Charitatos, Dimitris Michas, Marinos C. Dalakas
Format:	Article
Language:	English
Published:	SAGE Publishing 2016-01-01
Series:	Therapeutic Advances in Neurological Disorders
Online Access:	https://doi.org/10.1177/1756285615614812

Similar Items

A case report of rigidity and recurrent lower limb myoclonus: progressive encephalomyelitis rigidity and myoclonus syndrome, a chameleon
by: Aurélie Degeneffe, et al.
Published: (2018-10-01)

Progressive Encephalomyelitis With Rigidity and Myoclonus With Thymoma: A Case Report and Literature Review
by: Yana Su, et al.
Published: (2020-09-01)

Progressive Encephalomyelitis with Rigidity and Myoclonus in an Intellectually Disabled Patient Mimicking Neuroleptic Malignant Syndrome
by: Zheyu Xu, et al.
Published: (2017-05-01)

Anti-Glycine Receptor Antibody Mediated Progressive Encephalomyelitis with Rigidity and Myoclonus Associated with Breast Cancer
by: Sofie N. De Blauwe, et al.
Published: (2013-01-01)

Practical considerations on the use of rituximab in autoimmune neurological disorders
by: Mixalis L. Kosmidis, et al.
Published: (2010-03-01)

Progressive Encephalomyelitis with Rigidity and Myoclonus Associated With Anti-GlyR Antibodies and Hodgkin’s Lymphoma: A Case Report
by: Linda Borellini, et al.
Published: (2017-08-01)

Case Report: Dexmedetomidine for Intractable Clusters of Myoclonic Jerks and Paroxysmal Sympathetic Hyperactivity in Progressive Encephalomyelitis With Rigidity and Myoclonus
by: Yuzo Fujino, et al.
Published: (2021-07-01)

Anti-SARS-CoV-2 Antibodies Within IVIg Preparations: Cross-Reactivities With Seasonal Coronaviruses, Natural Autoimmunity, and Therapeutic Implications
by: Marinos C. Dalakas, et al.
Published: (2021-02-01)

Quantitative clinical and autoimmune assessments in stiff person syndrome: evidence for a progressive disorder
by: Goran Rakocevic, et al.
Published: (2019-01-01)

GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions
by: Popianna Tsiortou, et al.
Published: (2021-03-01)

Clinical Responses to Rituximab in a Case of Neuroblastoma with Refractory Opsoclonus Myoclonus Ataxia Syndrome
by: Samin Alavi, et al.
Published: (2012-01-01)

Rituximab Treatment in Acute Disseminated Encephalomyelitis Associated with Salmonella Infection
by: Ebru Kacmaz, et al.
Published: (2021-01-01)

Trismus as a Presenting Symptom in a Case of Progressive Encephalopathy with Rigidity and Myoclonus
by: Lies Blomme, et al.
Published: (2019-04-01)

brucellosis as trigger for autoimmune hepatitis in susceptible individual
by: Eman Sh. AL-Obeidy
Published: (2007-10-01)

Brucellosis as trigger for autoimmune hepatitis in susceptible individual
by: Eman Sh. Al-Obeidy
Published: (2008-01-01)

Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis.
by: Nancy L Monson, et al.
Published: (2011-02-01)

Prevalence and Possible Causes of Infertility in the Perm Region
by: A. P. Godovalov, et al.
Published: (2019-03-01)

Neurological complications of immune checkpoint inhibitors: what happens when you ‘take the brakes off’ the immune system
by: Marinos C. Dalakas
Published: (2018-09-01)

Advances in the diagnosis, immunopathogenesis and therapies of IgM-anti-MAG antibody-mediated neuropathies
by: Marinos C. Dalakas
Published: (2018-01-01)

Gene therapy for Duchenne muscular dystrophy: balancing good science, marginal efficacy, high emotions and excessive cost
by: Marinos C. Dalakas
Published: (2017-08-01)

Future perspectives in target-specific immunotherapies of myasthenia gravis
by: Marinos C. Dalakas
Published: (2015-11-01)

Review: Therapeutic advances and future prospects in immune-mediated inflammatory myopathies
by: Marinos C. Dalakas
Published: (2008-11-01)

Epileptic myoclonus
by: M. B. Mironov, et al.
Published: (2020-09-01)

Myoclonus Epilepsies
by: J Gordon Millichap
Published: (1990-08-01)

Palatal myoclonus
Published: (2001-01-01)

Palatal myoclonus
Published: (2001-03-01)

Inspiratory Myoclonus
by: Marieke C. J. Dekker, et al.
Published: (2019-02-01)

Rituximab Prevents the Development of Experimental Autoimmune Encephalomyelitis (EAE): Comparison with Prophylactic, Therapeutic or Combinational Regimens
by: Al-ani MR, et al.
Published: (2020-03-01)

Gliotoxin Aggravates Experimental Autoimmune Encephalomyelitis by Triggering Neuroinflammation
by: Thais Fernanda de Campos Fraga-Silva, et al.
Published: (2019-07-01)

PERM SCHOOL OF METAPHOR
by: Лариса Михайловна Алексеева (Larisa M. Alekseeva), et al.
Published: (2017-12-01)

Acute Brucellosis and Cirrhosis: The Triggering Event of Fatal Liver Decompensation
by: Maria Kosmidou, et al.
Published: (2020-01-01)

Myoclonus- A review
by: Mitesh Chandarana, et al.
Published: (2021-01-01)

Post-anoxic myoclonus
by: Pavis Laengvejkal, et al.
Published: (2014-04-01)

Myoclonus in Angelman Syndrome
by: J Gordon Millichap
Published: (1996-10-01)

Pathogenesis of Opsoclonus Myoclonus
by: J Gordon Millichap
Published: (2003-05-01)

Opsoclonus-Myoclonus Outcome
by: J Gordon Millichap
Published: (1995-08-01)

Myoclonus-Dystonia Syndrome
by: J Gordon Millichap
Published: (2002-11-01)

Epileptic Palatal Myoclonus
by: J Gordon Millichap
Published: (1991-09-01)

Essential Palatal Myoclonus
by: Bhuwan Raj Pandey, et al.
Published: (2017-06-01)

Myoclonus in Ataxia-Telangiectasia
by: Pichet Termsarasab, et al.
Published: (2015-03-01)

Cannot write session to /tmp/vufind_sessions/sess_c593jg5ph85g1cdcukd74tugij